647
Participants
Start Date
May 31, 2013
Primary Completion Date
December 31, 2013
Study Completion Date
March 31, 2014
LDV/SOF
LDV 90 mg/SOF 400 mg FDC tablet administered orally once daily
RBV
Ribavirin (RBV) tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)
Birmingham
La Jolla
Los Angeles
Palo Alto
Sacramento
San Diego
San Francisco
Aurora
Englewood
Washington D.C.
Gainesville
Jacksonville
Miami
Orlando
Wellington
Atlanta
Decatur
Marietta
Chicago
Indianapolis
Bowling Green
Baton Rouge
Baltimore
Lutherville
Boston
Novi
Kansas City
St Louis
Albuquerque
Berlin
Hillsborough
Santa Fe
Binghamton
Manhasset
New York
Chapel Hill
Fayetteville
Statesville
Winston-Salem
Philadelphia
Providence
Germantown
Nashville
Arlington
Houston
San Antonio
Fairfax
Falls Church
Newport News
Norfolk
Richmond
Seattle
Lead Sponsor
Gilead Sciences
INDUSTRY